{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T07:23:23Z","timestamp":1793085803048,"version":"4.5.0"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Circulation"],"published-print":{"date-parts":[[1999,8,3]]},"abstract":"<jats:p><jats:italic>Background<\/jats:italic>\u2014Cocaine is thought to stimulate the cardiovascular system by blocking peripheral norepinephrine reuptake. This study was designed to test the novel hypotheses that cocaine also stimulates the human cardiovascular system by (1) increasing central sympathetic outflow, or (2) decreasing parasympathetic control of heart rate.<\/jats:p><jats:p><jats:italic>Methods and Results<\/jats:italic>\u2014In 14 healthy cocaine-naive humans, we measured blood pressure, heart rate, and skin sympathetic nerve activity (SNA) with intraneural microelectrodes before, during, and for 90 minutes after intranasal cocaine (2 mg\/kg, n=7) or lidocaine (2 mg\/kg, n=7). Intranasal cocaine caused an initial but transient 3.3-fold increase in skin SNA during the period of intranasal administration followed by a sustained 2.4-fold increase lasting for up to 90 minutes after cocaine. Unlike cocaine, intranasal lidocaine caused only a small transient increase in skin SNA due to local nasal irritation. The cocaine-induced increase in SNA was accompanied by decreased skin blood flow, increased skin vascular resistance, and increased heart rate. In 11 additional subjects, we showed that the cocaine-induced increase in heart rate was eliminated by \u03b2-adrenergic receptor blockade (propranolol) but unaffected by muscarinic receptor blockade (atropine), indicating sympathetic mediation.<\/jats:p><jats:p><jats:italic>Conclusions<\/jats:italic>\u2014These studies provide direct microneurographic evidence in humans that intranasal cocaine stimulates central sympathetic outflow. This central sympathetic activation appears to be targeted not only to the cutaneous circulation promoting peripheral vasoconstriction but also to the heart promoting tachycardia.<\/jats:p>","DOI":"10.1161\/01.cir.100.5.497","type":"journal-article","created":{"date-parts":[[2012,6,12]],"date-time":"2012-06-12T00:42:29Z","timestamp":1339461749000},"page":"497-502","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":136,"title":["Cocaine Stimulates the Human Cardiovascular System via a Central Mechanism of Action"],"prefix":"10.1161","volume":"100","author":[{"given":"Wanpen","family":"Vongpatanasin","sequence":"first","affiliation":[{"name":"From the Divisions of Hypertension and Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Tex."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasser","family":"Mansour","sequence":"additional","affiliation":[{"name":"From the Divisions of Hypertension and Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Tex."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahman","family":"Chavoshan","sequence":"additional","affiliation":[{"name":"From the Divisions of Hypertension and Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Tex."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debbie","family":"Arbique","sequence":"additional","affiliation":[{"name":"From the Divisions of Hypertension and Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Tex."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald G.","family":"Victor","sequence":"additional","affiliation":[{"name":"From the Divisions of Hypertension and Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Tex."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_2_1_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0033-0620(97)80023-0"},{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-107-1-13"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198612043152302"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.85.2.1346509"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.841307"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198912073212301"},{"key":"e_1_3_2_7_2","first-page":"225","volume":"112","year":"1988","unstructured":"Karch SB, Billingham ME. The pathology and etiology of cocaine-induced heart disease. Arch Pathol Lab Med. 1988;112:225\u2013230.","journal-title":"Arch Pathol Lab Med"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/187604a0"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1961.tb01095.x"},{"key":"e_1_3_2_10_2","first-page":"39","volume":"142","year":"1963","unstructured":"Furchgott RF, Kirpeker SM, Rieker M, Schwab A. Action and interactions of norepinephrine, tyramine, and cocaine on aortic strips of rabbit and left atria guinea pig and cat. J Pharmacol. 1963;142:39\u201358.","journal-title":"J Pharmacol"},{"key":"e_1_3_2_11_2","unstructured":"Jaffe JH. Drug addiction and drug abuse. In: Gilman AG Rall TW Nies AS Taylor P eds. The Pharmacologic Basis of Therapeutics. New York: Pergamon Press; 1990:539\u2013546."},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0376-8716(94)01087-2"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-198905000-00012"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199312000-00015"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.87.3.8443913"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0376-8716(94)01086-Z"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(96)00279-2"},{"key":"e_1_3_2_18_2","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0022-3565(25)09491-1","volume":"273","year":"1995","unstructured":"Szabo B, Obergill A, Starke K. Involvement of monoamine uptake inhibition and local anesthesia in the cardiovascular response to cocaine in conscious rabbits. J Pharmacol Exp Ther. 1995;273:128\u2013137.","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_3_2_19_2","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S0022-3565(25)10408-4","volume":"263","year":"1992","unstructured":"Knuepfer MM, Branch CA. Cardiovascular responses to cocaine are initially mediated by the central nervous system in rats. J Pharmacol Exp Ther. 1992;263:734\u2013741.","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-1838(95)00130-1"},{"key":"e_1_3_2_21_2","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/S0022-3565(25)12899-1","volume":"277","year":"1996","unstructured":"Hernandez YM, Raczkowski VFC, Dretchen KL, Gillis RA. Cocaine inhibits sympathetic neural activity by acting in the central nervous system and at the sympathetic ganglion. J Pharmacol Exp Ther. 1996;277:1114\u20131121.","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199103000-00012"},{"key":"e_1_3_2_23_2","first-page":"H1890","volume":"264","year":"1993","unstructured":"Hageman GR, Simor T. Attenuation of the cardiac effects of cocaine by dizocilpine. Am J Physiol. 1993;264:H1890\u2013H1895.","journal-title":"Am J Physiol"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI119205"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-201X.1997.573344000.x"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.1979.59.4.919"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.1996.sp021359"},{"key":"e_1_3_2_28_2","first-page":"969","volume":"84","year":"1977","unstructured":"Johns ME, Henderson RL. Cocaine use by the otolaryngologist: a survey. Trans Am Acad Ophthalmology Otolaryngol. 1977;84:969\u2013973.","journal-title":"Trans Am Acad Ophthalmology Otolaryngol"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(92)90142-A"},{"key":"e_1_3_2_30_2","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0022-3565(25)12741-9","volume":"255","year":"1990","unstructured":"Kiritsy-Roy JA, Halter JB, Gordon SM, Smith MJ, Terry LC. Role of the central nervous system in hemodynamic and sympathoadrenal responses to cocaine in rats. J Pharmacol Exp Ther. 1990;255:154\u2013160.","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_3_2_31_2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0022-3565(25)32902-2","volume":"220","year":"1982","unstructured":"Christ D, Curry J, Zitaglio T. Potentiation of the ganglionic blocking action of norepinephrine by cocaine. J Pharmacol Exp Ther. 1982;220:97\u2013101.","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_3_2_32_2","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S0022-3565(25)22203-0","volume":"246","year":"1988","unstructured":"Sharkey J, Ritz MC, Schenden JA, Hanson RC, Kuhar MJ. Cocaine inhibits muscarinic cholinergic receptors in heart and brain. J Pharmacol Exp Ther. 1988;246:1048\u20131052.Cocaine is thought to stimulate the cardiovascular system by blocking peripheral norepinephrine reuptake. We tested whether cocaine also stimulates the human cardiovascular system by (1) increasing central sympathetic outflow, or (2) decreasing parasympathetic control of heart rate. In healthy human subjects, intranasal cocaine caused a sustained increase in skin sympathetic nerve activity and heart rate which was eliminated by propranolol but unaffected by atropine, indicating sympathetic mediation. Intranasal lidocaine exerted no significant effect. In healthy humans, cocaine acts centrally to increase sympathetic outflow both to the cutaneous bed, promoting peripheral vasoconstriction, and to the heart, promoting tachycardia.","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/01.CIR.100.5.497","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T21:14:27Z","timestamp":1743369267000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/01.CIR.100.5.497"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,8,3]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1999,8,3]]}},"alternative-id":["10.1161\/01.CIR.100.5.497"],"URL":"https:\/\/doi.org\/10.1161\/01.cir.100.5.497","relation":{},"ISSN":["0009-7322","1524-4539"],"issn-type":[{"value":"0009-7322","type":"print"},{"value":"1524-4539","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,8,3]]},"assertion":[{"value":"1999-03-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"1999-05-06","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"1999-08-03","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}